MAIA Biotechnology
MAIA
#9471
Rank
A$93.19 M
Marketcap
$3.56
Share price
3.49%
Change (1 day)
116.54%
Change (1 year)

P/E ratio for MAIA Biotechnology (MAIA)

P/E ratio as of January 2025 (TTM): -1.41

According to MAIA Biotechnology's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.40764. At the end of 2022 the company had a P/E ratio of -2.30.

P/E ratio history for MAIA Biotechnology from 2022 to 2023

202320242025-2-110companiesmarketcap.com

PE ratio at the end of each year

Year P/E ratio Change
2022-2.30

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.